Precigen is a biopharmaceutical company that develops gene medicines for patients with cancer, autoimmune and infectious diseases. It last closed at $4.21 on Nov 20, up 1.20% on the day. The next earnings report for PGEN is expected around Wed, Mar 24, 2027, after the close. For the quarter ended Sep 2026, PGEN reported EPS of $0.08 on revenue of $74.1M, with revenue up 2437.6% from a year ago. Over its last 8 reports the stock moved an average of 11.8% the session after earnings. Over the last 12 months PGEN insiders bought $25K of stock on the open market and sold $44.8M, according to SEC Form 4 filings.
AI Auto Pilots
Is PGEN in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold PGEN.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on PGENStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
PGEN · as of the Nov 20 close · updated each morning
Turning down, nearing oversold
The stock is 19% below its 20 day and 54% below its 50 day average. It is 25% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 32), near oversold. The nearest support is the swing low (May 27) at $4.11, and the nearest resistance the Pivot R1 at $4.36.
Short trendBearish
Long trendNeutral
MomentumWeak
StretchNear oversold
VolatilityHigh, 10.0%/day
Key levels
$8.9852 week high+113.3%
$6.4850 day average+53.9%
$6.39100 day average+51.8%
$5.27200 day average+25.2%
$5.0220 day average+19.2%
$4.68Swing high (May 28)+11.2%
$4.36Pivot R1+3.6%
$4.21Pivot+0.0%
$4.21Last close
$4.11Swing low (May 27)−2.4%
$4.07Pivot S1−3.3%
$3.0452 week low−27.8%
Indicators
RSI (14)
31.96
Weak, oversold below 30
Neutral
MACD
-0.67
Below its signal line
Bearish
Stochastic
15.5
Near the bottom of its range
Oversold
ADX (14)
29.7
Trending down
Williams %R
-80.1
Oversold below −80, overbought above −20
Oversold
CCI (20)
-76.0
Oversold below −100, overbought above 100
Neutral
Rate of change
−5.8%
Change over 10 sessions
Bearish
ATR (14)
$0.42
Typical daily range, 10.0% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Pullback inside a longer uptrend, nearing oversold
Short trendBearish
Long trendBullish
MomentumWeak
StretchNear oversold
VolatilityNormal, 24.6%/day
Key levels
$8.9852 week high+113.3%
$6.4850 day average+53.9%
$6.39100 day average+51.8%
$5.27200 day average+25.2%
$5.0220 day average+19.2%
$4.68Swing high (May 28)+11.2%
$4.36Pivot R1+3.6%
$4.21Pivot+0.0%
$4.21Last close
$4.11Swing low (May 27)−2.4%
$4.07Pivot S1−3.3%
$3.0452 week low−27.8%
Indicators
RSI (14)
40.25
Middle of its range
Neutral
MACD
0.06
Below its signal line
Bearish
Stochastic
9.6
Near the bottom of its range
Oversold
ADX (14)
38.7
Trending down
Williams %R
-94.3
Oversold below −80, overbought above −20
Oversold
CCI (20)
-147.8
Oversold below −100, overbought above 100
Oversold
Rate of change
−38.5%
Change over 10 sessions
Bearish
ATR (14)
$1.04
Typical daily range, 24.6% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Above
MA 200Above
What happened before, for PGEN
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how PGEN did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow PGEN usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for PGENHow many large options trades hit PGEN, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in PGEN in the last 90 days.
From SEC Form 4 filings by PGEN's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether PGEN is in one of them and how their past PGEN trades turned out.
Precigen is a biopharmaceutical company based in Germantown, Maryland, that develops medicines for patients with hard to treat diseases. Its main focus areas are cancer, autoimmune disorders and infectious diseases. Its approved product, Papzimeos, is an immunotherapy for adults with recurrent respiratory papillomatosis, a rare disease caused by HPV infection. The company also develops cell and gene therapies that are in clinical trials or at earlier research stages.